222 related articles for article (PubMed ID: 2467013)
1. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R
J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
Oesterling JE; Chan DW; Epstein JI; Kimball AW; Bruzek DJ; Rock RC; Brendler CB; Walsh PC
J Urol; 1988 Apr; 139(4):766-72. PubMed ID: 2451037
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of prostate specific antigen in patients with prostate cancer.
Hudson MA; Bahnson RR; Catalona WJ
J Urol; 1989 Oct; 142(4):1011-7. PubMed ID: 2477559
[TBL] [Abstract][Full Text] [Related]
5. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
[TBL] [Abstract][Full Text] [Related]
6. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
[TBL] [Abstract][Full Text] [Related]
7. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
Carter HB; Partin AW; Epstein JI; Chan DW; Walsh PC
J Urol; 1990 Nov; 144(5):1167-70; discussion 1170-1. PubMed ID: 1700143
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
Stamey TA; Kabalin JN; Ferrari M
J Urol; 1989 May; 141(5):1084-7. PubMed ID: 2468796
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
10. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome.
Cheng WS; Bergstralh EJ; Frydenberg M; Zincke H
Eur Urol; 1994; 25(3):189-93. PubMed ID: 7515348
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation).
Morgan WR; Zincke H; Rainwater LM; Myers RP; Klee GG
J Urol; 1991 Feb; 145(2):319-23. PubMed ID: 1703241
[TBL] [Abstract][Full Text] [Related]
13. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
14. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels.
Lange PH; Lightner DJ; Medini E; Reddy PK; Vessella RL
J Urol; 1990 Oct; 144(4):927-32; discussion 932-3. PubMed ID: 1697918
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.
Winter HI; Bretton PR; Herr HW
Urology; 1991 Sep; 38(3):202-5. PubMed ID: 1716021
[TBL] [Abstract][Full Text] [Related]
16. Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer.
Bigg SW; Kavoussi LR; Catalona WJ
J Urol; 1990 Dec; 144(6):1420-4. PubMed ID: 1700156
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
Stamey TA; Kabalin JN
J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen and local recurrence after radical prostatectomy.
Lightner DJ; Lange PH; Reddy PK; Moore L
J Urol; 1990 Oct; 144(4):921-6. PubMed ID: 1697917
[TBL] [Abstract][Full Text] [Related]
19. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
[TBL] [Abstract][Full Text] [Related]
20. The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
Burnett AL; Chan DW; Brendler CB; Walsh PC
J Urol; 1992 Dec; 148(6):1832-4. PubMed ID: 1279226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
